EMA gives positive scientific advice on development plan and regulatory pathway for AM-111 May 8, 2018 No Comments
Cas9-Tmc1-mut3 RNP genome editing agent shows promise in model of autosomal dominant hearing loss Jan. 9, 2018 No Comments
Frequency Therapeutics completes first-in-human study of drug candidate for hearing loss Dec. 22, 2017 No Comments
HEALOS phase III study of AM-111 does not meet the primary efficacy endpoint Nov. 29, 2017 No Comments
NXT-596 demonstrates gamma-secretase inhibition as a therapeutic strategy against hearing loss Nov. 20, 2017 No Comments
RSS